Dr. Agarwal's Healthcare IPO Day 3: Check GMP, Subscription Status & Key Highlights

The subscription window for Dr Agarwal's Healthcare IPO will be closed by today. The allotment for Dr Agarwal's Healthcare IPO is expected to be finalized on Monday, February 3, 2025. Dr Agarwal's Healthcare IPO will list on BSE, NSE, with a tentative listing date scheduled for Wednesday, February 5, 2025.

Dr. Agarwal’s Healthcare IPO Day 3 Subscription Status 

(January 31, 2025, 10:53 AM (Day 3)

Dr. Agarwal’s Healthcare IPO was subscribed 0.45 times overall. The public issue saw a subscription of 0.28 times in the retail category, 1.01 times in the Qualified Institutional Buyers (QIB) segment, and 0.15 times among Non-Institutional Investors (NII). Within the NII category, bids from large investors (bNII) subscribing above ₹10 lakh reached 0.1 times, while small investors (sNII) bidding below ₹10 lakh subscribed 0.24 times. The employee segment recorded a 0.19 times subscription, while other investors subscribed 0.29 times. 

Dr. Agarwal Healthcare IPO GMP (Grep Market Premium)

As per Live Mint, the last reported Grey Market Premium (GMP) for Dr. Agarwal's IPO stood at ₹1.5. With the IPO price band set at ₹402.00 per share, the estimated listing price is projected to be ₹403.5, reflecting a modest expected gain of 0.37% per share.

Note: The Grey Market Premium (GMP) is not an official price and is based on market speculation.

Dr. Agarwal’s Healthcare IPO Details

Dr. Agarwal’s Healthcare has launched its IPO as a book-built issue worth ₹3,027.26 crores. The offering includes a fresh issue of 0.75 crore shares, raising ₹300 crores, along with an offer for sale of 6.78 crore shares, totaling ₹2,727.26 crores. The price band for the IPO is set between ₹382 and ₹402 per share. Retail investors can participate with a minimum lot size of 35 shares, requiring an investment of ₹14,070. For small non-institutional investors (sNII), the minimum application is 15 lots (525 shares), amounting to ₹2,11,050, while large non-institutional investors (bNII) need to apply for at least 72 lots (2,520 shares), requiring an investment of ₹10,13,040.

Utilization of IPO Proceeds

The company plans to allocate the net proceeds from the fresh issue toward key financial objectives, including the partial or full repayment of specific borrowings. Additionally, a portion of the funds will be used for general corporate purposes and potential inorganic acquisitions, which remain undisclosed at this stage.

Dr. Agarwal’s Health Care Limited Business Overview

Founded in 2010, Dr. Agarwal's Health Care Limited is a leading provider of specialized eye care services, offering treatments such as cataract and refractive surgeries, consultations, diagnostics, non-surgical procedures, and a range of optical products, including contact lenses, accessories, and eye care pharmaceuticals.

As of September 30, 2024, the company had a team of 737 doctors catering to patients across its network. Over this period, it treated 2.13 million patients and performed 220,523 surgeries. In the first half of the financial year, up to September 30, 2024, the company served 1.15 million patients and conducted 140,787 surgical procedures.

Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market nor do we recommend or endorse trading in the grey market.